Simplex Trading’s Oric Pharmaceuticals ORIC Stock Holding History

Simplex Trading’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.07K	Buy	+400	New	+$4.54K	﹤0.01%	7887
2025 Q2	–	Sell	-1,000	Closed	-$5K	–	9450
2025 Q1	$5K	Buy	+1,000	New	+$8.74K	﹤0.01%	7572
2024 Q2	–	Sell	-800	Closed	-$11K	–	9540
2024 Q1	$11K	Buy	+800	New	+$9.5K	﹤0.01%	7556
2023 Q3	–	Sell	-11,800	Closed	-$91K	–	9503
2023 Q2	$91K	Buy	+11,800	New	+$67K	﹤0.01%	5191
2023 Q1	–	Sell	-200	Closed	-$1K	–	9829
2022 Q4	$1K	Sell	200 -47,400	-100%	-$160K	﹤0.01%	8880
2022 Q3	$152K	Hold	47,600	–	–	﹤0.01%	4972
2022 Q2	$213K	Buy	+47,600	New	+$190K	﹤0.01%	4527

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Simplex Trading's ORIC Position: Q1 2026 in Review

Simplex Trading increased its Oric Pharmaceuticals (ORIC) stake by 172% in Q1 2026, buying an estimated $9.67K and bringing the position to 1,348 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6895.

Simplex Trading first reported a position in ORIC in Q2 2021 and has held it in 12 quarters since. The position peaked at $225K in Q2 2023. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

Simplex Trading held 1,348 shares of Oric Pharmaceuticals worth $17.1K as of Q1 2026.
Simplex Trading bought 852 Oric Pharmaceuticals shares in Q1 2026, an estimated $9.67K.
Oric Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6895 holding.
Simplex Trading first reported a position in Oric Pharmaceuticals in Q2 2021 and has held it in 12 quarters since.
Simplex Trading's Oric Pharmaceuticals position peaked at $225K in Q2 2023.
182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.